Articles tagged with Vaccine Research
A recent study published in Cell found that T cell responses are still robust against the Omicron variant in most individuals with prior SARS-CoV-2 infection or vaccination, offering protection against severe disease. Booster vaccines can enhance T cell responses, substantially increasing immunity against severe COVID-19.
Researchers attribute vaccine effectiveness to mutations shared with previous variants, resulting in relatively small severe cases and deaths among vaccinated patients. The study analyzed over 200,000 genomes and found identical mutations that could serve as targets for future vaccines.
The IEEE forum identified four major challenges to address during the pandemic: healthcare, screening, tracing, and treatment. The panel highlighted socioeconomic and education status as critical factors impacting mortality rates and hospital admission lengths.
A phase 2 clinical trial found that the Australian-developed neonatal rotavirus vaccine RV3-BB was safe and produced a robust immune response in African babies. The reduced dose of the vaccine generated an equivalent immune response as the highest dose, offering opportunities to reduce vaccine manufacturing costs.
The first US peer-reviewed study on omicron patient outcomes found significant differences in infection behavior. Ominron patients are significantly younger, have increased vaccine breakthrough rates, and are less likely to be hospitalized compared to patients with alpha or delta variants.
A study at a midwestern university examined the relationship between vaccine coverage and the transmission of SARS-CoV-2 variants during in-person learning. The results showed a correlation between higher vaccination rates and reduced spread of variants, highlighting the effectiveness of vaccines in mitigating COVID-19 transmission.
Scientists successfully produced SARS-CoV-2 protein fragments linked to bacterial flagellin in plants, enabling high-yield production and scalable vaccine development. This novel approach could make vaccines cheaper and more convenient.
Researchers at Boston University found no association between COVID-19 vaccination and conception likelihood in female or male partners. However, COVID-19 infection was linked to reduced fertility in men, particularly those testing positive within 60 days of a cycle.
Four COVID-19 vaccines prompt the body to make effective, long-lasting T cells against SARS-CoV-2. These T cells can recognize variants of concern, including Delta and Omicron. Fully vaccinated people have fewer memory B cells and neutralizing antibodies against the Omicron variant.
Researchers are working tirelessly to develop vaccines against the Omicron variant, a crucial step in combating the pandemic. By understanding the biology of Omicron, scientists hope to create effective treatments and boosters to protect against future pandemics.
A new study found that Black Americans who were initially hesitant about receiving a COVID-19 vaccine warmed up to the idea as the pandemic wore on and viewed vaccines as necessary for protection. The research highlights the importance of addressing access barriers, not just distrust or skepticism.
Researchers at the University of Missouri identified 46 specific mutations in the Omicron variant that enable it to evade pre-existing antibodies. These mutations are particularly prevalent in the region where antibodies bind to the virus, making them a key target for future antiviral treatments.
A new study by Boston University School of Public Health investigators finds that COVID-19 vaccination in either partner does not impair fertility. In contrast, males who test positive for COVID within 60 days of a cycle have reduced fertility compared to uninfected men.
A new study by Yale researchers found that the Sinovac vaccine, widely used in 48 countries, offers little protection against the Omicron variant. Booster shots are necessary to combat the dominant circulating virus, which has shown to produce no neutralizing antibodies among those who received two doses of the Sinovac vaccine.
A new study published in the Journal of the American Medical Association finds that those who received the Moderna COVID-19 mRNA vaccine have a lower risk of experiencing 'breakthrough' COVID-19 cases compared to recipients of the Pfizer-BioNTech mRNA vaccine. The study also found that Moderna recipients were less likely to be hospital...
A new study has found that children in sub-Saharan Africa who are hospitalized with COVID-19 are dying at a rate far greater than children in the US and Europe. Children under 1 year old had nearly five times the risk of death compared to adolescents aged 15-19 years.
Researchers at Lund University discovered that non-neutralising antibodies can also protect against Covid-19 by facilitating phagocytosis. The findings suggest that broader protection from antibodies may be more effective in combating mutations of the virus.
A new study from USC researchers sheds light on COVID-19 vaccine inequities in California, revealing disparities in vaccination rates among vulnerable populations. The study suggests that targeted community outreach and improved vaccine access can help reduce these disparities.
A new study by the University of North Carolina at Chapel Hill suggests that COVID-19 vaccines maintain protection from severe disease nine months after the first shot. Boosters are crucial for older adults, according to lead author Danyu Lin, PhD.
A unique Irish study found that previous COVID-19 infection and age are associated with lower antibody levels six months after vaccination. The research highlights the importance of boosting vaccinations for vulnerable populations like nursing home residents.
A case series found that a fourth dose of an mRNA-based vaccine increases antispike IgG titers in kidney transplant recipients with weak serologic response after three doses. The researchers noted no safety concerns with the additional dose and suggested its use for such patients.
Researchers found that even unrelated vaccines can provide cross-protection against multiple pathogens, reducing caseloads and hospital usage. Vaccinating vulnerable populations with other vaccines during the pandemic can have a substantial impact.
A University of Massachusetts Amherst study found that vaccinated women transfer SARS-CoV-2 antibodies to their breastfed infants, potentially giving them passive immunity against the coronavirus. The research also showed a correlation between vaccine side effects and antibody levels in infant stool.
A new study found that COVID-19 vaccination during pregnancy elicits high levels of antibodies in both mother and baby, regardless of when it occurs. The research suggests that pregnant women should not delay vaccination until late pregnancy, as it is likely to be beneficial for themselves and their babies.
Researchers developed a fair-diverse allocation optimization framework to optimize the distribution of COVID-19 vaccines, treatments, and testing supplies. The model aims to get limited resources to the most vulnerable subgroups while ensuring fairness and diversity, independent of demographic background.
Researchers found that mRNA vaccines were highly effective (86%) in preventing SARS-CoV-2-related deaths among vaccinated individuals, especially in the elderly population. However, vaccine effectiveness against infection was lower (69%) and decreased with increasing age and comorbidity burden.
The study found that two doses of Moderna and Pfizer vaccines produced higher antibody concentrations than a single dose of Johnson & Johnson vaccine, with levels more than 10 times higher for recovered COVID-19 patients. The analysis also showed that the Moderna vaccine had the lowest risk for breakthrough infections.
Researchers have discovered a fundamental role of the TBK1 enzyme in deciding B cell fate, crucial for developing effective vaccines for diseases like COVID-19 and malaria. The study reveals that TBK1 is necessary for germinal center formation and high-quality antibody production.
Research from Queen Mary University of London and Cardiff University found that certain MS treatments can reduce Covid-19 vaccine effectiveness in people with MS. The largest peer-reviewed study on the topic provides high-quality evidence to inform clinicians' guidance on treatment options.
A new blood test developed at Hebrew University of Jerusalem detects immune and inflammatory activity in tissues by monitoring circulating DNA fragments. This method provides accurate information about immune processes in remote tissues, removing the need for invasive measures.
The COVID-19 pandemic drove significant advancements in pharmaceutical technology, with mRNA-based vaccines proving highly effective. Oral antiviral pills, such as Merck's molnupiravir and Pfizer's PF-0732133, showed promise in reducing hospitalization and death rates among unvaccinated individuals.
Researchers from Harvard University and others have found that large-scale COVID-19 vaccination surveys were off by up to 17 percentage points due to systematic biases in the data. The 'Big Data Paradox' highlights how big data sets can minimize one type of error while magnifying another, leading to misleading results.
A UK trial shows six different COVID-19 boosters are safe and stimulate strong immune responses in people who have previously received a two-dose course of ChAdOx1-nCov19 or BNT162b2, according to the first randomised trial of boosters given after two doses. The study found varying levels of protection against COVID-19 infection and ho...
A large-scale study of over 1.2 million people found breakthrough COVID-19 infections are rare but more frequent and severe in those with weakened immune systems. The study supports the introduction of a third vaccine dose for immunocompromised individuals to increase protection.
A national analysis found that children with poorly controlled asthma are more likely to require hospitalisation than those with well-controlled asthma or without asthma. Vaccinating this group can reduce the risk of COVID-19 infection and associated illness.
A Kaiser Permanente study found the Moderna COVID-19 vaccine to be 87% effective in preventing COVID-19 infection and 96% effective in preventing hospitalization. The vaccine's effectiveness persisted even among those with underlying conditions, providing reassurance about its durability.
A study using GDPR-compliant mobile phone data found significant decreases in household mixing during the first two lockdowns, but increases during the third, coinciding with the vaccine rollout.
A study found that covid infection risk gradually increases after a second vaccine dose, with protection waning over time. The research suggests that a third (booster) dose might be warranted to prevent breakthrough infections.
Antibodies that mimic the SARS-CoV-2 virus may explain lingering symptoms of long-haul COVID-19 and rare vaccine side effects like allergic reactions and blood-clotting. This theory, based on classic immunological concepts, suggests a cascade of immune responses that can lead to adverse effects.
A new study from the University of Georgia found that vaccination results in a more robust immune response than natural infection. Even with waning antibodies, vaccinated individuals still have protective immunity against severe disease and hospitalization.
A retrospective cohort analysis found that an algorithm-based automated text messaging system saved lives and reduced mortality rates by 68% among patients with COVID-19. The system, called COVID Watch, used text messages to monitor symptoms and escalate patients to healthcare providers for further care.
A new study by CUNY SPH found that COVID-VAC scale can inform targeted interventions to increase vaccine uptake among hesitant groups. Key motivators for vaccination included protecting oneself and loved ones from COVID-19, with continued testing crucial in combating misconceptions.
A systematic review of 28 studies identified 13 themes related to COVID-19 vaccination status in older, ethnic minority individuals. Factors facilitating access included vaccination reminders from healthcare providers, while misinformation and personal beliefs were barriers to uptake.
A new study published in The Lancet confirms that HPV vaccination has led to a significant reduction in cervical cancer rates in England. Women who were vaccinated between the ages of 12-13 had an 87% lower incidence of cervical cancer compared to previous generations.
Scientists have developed a software that adds missing sugar components to protein models created with AlphaFold, enabling more accurate structural predictions. This breakthrough has the potential to revolutionize workflows in biology, allowing scientists to understand proteins and their mutations faster than ever.
A massive Israeli study found that a third COVID-19 vaccine dose reduces hospitalization and severe disease risks by up to 93% compared to two doses. The research provides valuable insights into the effectiveness of booster shots in real-world settings.
A 51-country survey reveals that people who feel invincible to COVID-19 are less likely to get vaccinated and believe in the importance of individual actions. The study suggests that messaging emphasizing collective action is crucial in individualistic cultures.
Researchers have opened a novel study for a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease. The phase I trial will determine the maximum tolerated dose of the vaccine in patients with early-stage triple-negative breast cancer.
A study published in International Journal of Molecular Sciences found that the Sputnik-V COVID vaccine elicits both robust antibody and T-cell responses. The research suggests that long-term immunity is possible, supporting the effectiveness of the vaccine against local virus variants.
A recent study by Cedars-Sinai Medical Center found that COVID-19 mRNA vaccines induced detectable antibodies in 99% of patients with bowel disease, regardless of their immunocompromising therapies. Researchers also noted a correlation between the antibody response and effective immunity in the community.
A new study published in The New England Journal of Medicine has found no correlation between COVID-19 vaccinations and risk of first-trimester miscarriages. Vaccination during pregnancy is safe and provides protection to the newborn infant against COVID-19 infection.
Research from University of Pennsylvania team shows that vaccine mandates have positive effects on vaccination intentions, particularly for those who oppose forced behavior. Mandates strengthen vaccination intentions, regardless of racial or ethnic group, and for individuals with a disposition towards psychological reactance.
A new study from Karolinska Institutet finds that two vaccine doses increase antibody levels in the airways after COVID-19, while a second dose after recovery also boosts levels. The results highlight the importance of completing vaccination with a second dose to achieve optimal immune responses and reduce transmission.
Researchers quantified COVID-19 vaccine uptake disparities by race and ethnicity within US states, revealing substantial coverage gaps among older adults. The study's findings underscore the need for targeted vaccination strategies to address these disparities.
The study shows that COVID-19 vaccine effectiveness is substantial in adolescents, with a 93% decrease in symptomatic cases and a 90% decrease in documented infections after the second dose. Vaccine effectiveness was lower but still significant before the second dose.
Researchers at West Virginia University discovered a significant relationship between Christian nationalism and vaccine hesitancy, citing a national sample of 2,000 U.S. adults. They found that individuals embracing this ideology are less likely to receive the COVID-19 vaccine and express skepticism towards science.
Researchers found that vaccinating more people with a single dose can be beneficial when the vaccine waning rate is low, slowing the spread of the virus. The 'prime first' strategy prioritizes speed over double doses under supply constraints, offering an alternative to traditional vaccination protocols.
A new study found that infants with high levels of antibody-dependent cellular cytotoxicity (ADCC) against their mother's strain of HIV are less likely to get infected through breastfeeding. The study also showed that ADCC is more effective than neutralizing antibodies in protecting infants against HIV transmission and improving outcomes.
A nationwide study in Sweden found that receiving a mix-and-match COVID-19 vaccine schedule reduced the risk of infection by up to 79%. The study, published in The Lancet Regional Health - Europe, showed greater risk reduction for people who received an mRNA vaccine after having received a first dose of a vector-based vaccine.
Patients with multiple myeloma often mount a poor antibody response to COVID-19 vaccines and have a weak T cell response, underscoring the need for booster vaccination and safety precautions. Researchers found that these patients are at high risk of severe COVID-19 infection.